Back to All Events

Gastrointestinal Drugs Advisory Committee Meeting

  • IQVIA Solutions Denmark A/S Denmark (map)

The USFDA has scheduled a Gastrointestinal Drugs Advisory Committee (GIDAC) meeting on Friday, May 18, 2023. The committee will meet to discuss new drug application (NDA- 212833) for Obeticholic acid (OCA) 25 mg oral tablets, submitted by Intercept Pharmaceuticals, Inc., for the treatment of pre-cirrhotic liver fibrosis due to nonalcoholic steatohepatitis.

Source:: https://www.fda.gov/advisory-committees/committees-and-meeting-materials/may-19-2023-meeting-gastrointestinal-drugs-advisory-committee-meeting-announcement-05192023#event-materials
Earlier Event: May 18
Vaccines and Related Biological Products Advisory Committee
Later Event: June 8
Antimicrobial Drugs Advisory Committee